Banka BioLoo
NSE: BANKA · ISIN INE862Y01015 · Industrials
₹83.12−2.35 (−2.75%)
Monday 9 November, 11:18 IST. Delayed. Source: Yahoo Finance.
Price chart
This chart is unavailable right now.
The day
- Previous close
- ₹85.47
- Open
- ₹81.50
- Day high
- ₹89.70
- Day low
- ₹81.50
Listed on NSE since 29 October 2020.
Key numbers
- Market value
- ₹90.79 Cr
- P/E (trailing)
- 307.85
- EPS (trailing)
- ₹0.27
- Price to book
- 2.32
- Dividend yield
- 0.00%
- Debt to equity
- 0.96
- Profit margin
- 0.6%
- Beta
- 1.19
- Volume today
- 2,107
- Average volume
- 3,916
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹42.35 Cr | ₹2.54 Cr |
| FY24 | ₹50.00 Cr | ₹-65.25 L |
| FY25 | ₹54.17 Cr | ₹-8.92 Cr |
| FY26 | ₹57.09 Cr | ₹35.13 L |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | ₹11 Cr | ₹-1.34 L | −362.7% |
| Q4 FY26Jan–Mar 2026Audited | ₹18 Cr | ₹2 Cr | – |
| Q3 FY26Oct–Dec 2025 | ₹15 Cr | ₹-14.88 L | – |
| Q2 FY26Jul–Sep 2025 | ₹13 Cr | ₹-1 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹11 Cr | ₹51,000 | – |
| Q4 FY25Jan–Mar 2025Audited | ₹15 Cr | ₹-2 Cr | – |
Source: Banka BioLoo’s results filed with NSE, consolidated (the whole group). Net profit is the share of Banka BioLoo’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | March 2026 | September 2025 |
|---|---|---|
| Fixed assets | ₹27 Cr | ₹25 Cr |
| Investments | ₹7.31 L | ₹7.53 L |
| Inventories | ₹6 Cr | ₹6 Cr |
| Owed by customers | ₹29 Cr | ₹26 Cr |
| Cash and equivalents | ₹10 Cr | ₹7.29 L |
| Total assets | ₹101 Cr | ₹80 Cr |
| Borrowings | ₹39 Cr | ₹32 Cr |
| Total liabilities | ₹58 Cr | ₹49 Cr |
| Shareholders’ equity | ₹40 Cr | ₹31 Cr |
Source: Banka BioLoo’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Banka BioLoo
Banka BioLoo Limited engages in the wastewater treatment business in India. The company is involved in setting up, operation, and maintenance of faecal sludge treatment plants, wastewater treatment plants, and effluent treatment plants. It also offers biotoilet, biodigester, and footloo; and packaged sewage treatment plant and sewage treatment plant. In addition, the company provides Urban SaaS, a STP as a service for wastewater management in urban areas; and Pluto Geobag Fecal Sludge Treatment Plant. Further, it engages in design, installation, monitoring, and maintenance of bio-toilet for Indian railways. The company serves government and public, real estate and commercial developers, commercial and retail, and industrial and corporate customers. The company was incorporated in 2012 and is based in Hyderabad, India.
- Industry
- Pollution & Treatment Controls
- Based in
- Hyderabad
- Employees
- 818
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Banka BioLoo in the last day or two.
Dividends and corporate actions
All companies- Annual General Meeting
Action · ex-date 1 August 2024
- Annual General Meeting
Action · ex-date 18 September 2023
- Annual General Meeting
Action · ex-date 21 September 2022
- Annual General Meeting
Action · ex-date 21 September 2021
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.